GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » 5-Year ROIIC %

Stenocare AS (OCSE:STENO) 5-Year ROIIC % : -428.02% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Stenocare AS's 5-Year ROIIC % for the quarter that ended in Dec. 2024 was -428.02%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Stenocare AS's 5-Year ROIIC % or its related term are showing as below:

OCSE:STENO's 5-Year ROIIC % is ranked worse than
97.23% of 940 companies
in the Drug Manufacturers industry
Industry Median: 4.31 vs OCSE:STENO: -428.02

Stenocare AS 5-Year ROIIC % Historical Data

The historical data trend for Stenocare AS's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS 5-Year ROIIC % Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
5-Year ROIIC %
Get a 7-Day Free Trial - - - -39.14 -428.02

Stenocare AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.14 - - - -428.02

Competitive Comparison of Stenocare AS's 5-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stenocare AS's 5-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Stenocare AS's 5-Year ROIIC % falls into.


;
;

Stenocare AS 5-Year ROIIC % Calculation

Stenocare AS's 5-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -32.9894148 (Dec. 2024) - 3.3024924 (Dec. 2019) )/( 17.323 (Dec. 2024) - 8.844 (Dec. 2019) )
=-36.2919072/8.479
=-428.02%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Stenocare AS  (OCSE:STENO) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Stenocare AS 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Stenocare AS's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stenocare AS Business Description

Traded in Other Exchanges
N/A
Address
Nyholmsvej 4, Randers NØ, DNK, 8930
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines